Neuralink Nears First Blindsight Implant to Restore Vision

FREMONT, Calif. — Neuralink is preparing for one of the most ambitious experiments in its history: implanting its Blindsight device in a fully blind human for the first time, a step that could begin restoring a form of vision through a chip placed directly in the brain.

Company founder Elon Musk has said Neuralink is ready for the procedure and is awaiting final regulatory clearance. If approved, it would extend the company's work from helping paralyzed patients control computers to giving sight to people who have lost it entirely — or never had it.

How Blindsight Works

Blindsight bypasses the eyes and optic nerve altogether. A camera captures the scene, and processed signals are transmitted wirelessly to an implant embedded in the brain's primary visual cortex, where an array of electrodes stimulates neurons to create points of light called phosphenes.

Researchers describe the first experience as something like early video-game graphics — a grid of bright and dark dots that the brain gradually learns to interpret. Crude at first, the resolution is expected to climb sharply as the hardware advances, with Neuralink already developing a next-generation implant carrying roughly three times the channel count of today's device. The same rapid iteration that has defined Neuralink's expanding Telepathy trials is now being aimed at vision.

Building on Telepathy

The Blindsight push comes as Neuralink's flagship Telepathy program continues to grow, with participants using their implants to control phones and computers by thought alone, and the fastest typist mapping imagined finger movements to reach dozens of words per minute. Those results have built the safety record and surgical experience the company is now leaning on for its move into vision.

It is part of a broader Musk-world thesis that real-world AI and human capability advance together — the same conviction driving Tesla's push toward production-ready humanoid robots. In each case, software, sensors, and silicon are being pointed at problems once thought intractable.

A New Frontier for Medicine

For the millions of people living with blindness, even low-resolution artificial vision could be transformative — restoring the ability to navigate a room, recognize shapes, or sense a loved one's presence. Musk has said Neuralink could restore partial vision within the coming year, and the company has trademarked the Blindsight name as it moves toward trials.

If the first implant succeeds, it would mark a turning point not just for Neuralink but for the entire field of neurotechnology — proof that a brain-computer interface can give back one of the senses, and a powerful sign of what is still to come.